edatrexate has been researched along with Neutropenia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bodurtha, A; Boos, G; Bramwell, V; Eisenhauer, E; Knowling, M; Quirt, I | 1 |
| Crowley, JJ; Edelman, MJ; Gandara, DR; Lau, DH; Livingston, RB | 1 |
2 trial(s) available for edatrexate and Neutropenia
| Article | Year |
|---|---|
Phase II trial of 10-EDAM in advanced soft tissue sarcoma. A study of the Canadian Sarcoma Group and the National Cancer Institute of Canada Clinical Trials Group.
Topics: Adult; Aged; Aminopterin; Antineoplastic Agents; Canada; Female; Folic Acid Antagonists; Humans; Male; Middle Aged; Mouth Mucosa; Neutropenia; Sarcoma; Soft Tissue Neoplasms; Stomatitis | 1994 |
Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer: a Southwest Oncology Group study.
Topics: Adult; Aged; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Drug Administration Schedule; Female; Humans; Lung Neoplasms; Male; Middle Aged; Mouth Mucosa; Neutropenia; Survival Analysis; Treatment Outcome | 1997 |